Zdrowie i gospodarka · 13/03/2020

FDA Releases Revised Guidance on Biological Product Deviation Reporting for Blood and Plasma Establishments

The Food and Drug Administration has published a revised final guidance document to help blood and plasma establishments determine when to report biological product deviations, who submits the report, and how to submit it, with the goal of improving clarity and streamlining the process.